Morgan, M. R. (2009) “Regulation of Innovation Under Follow-On Biologics Legislation: FDA Exclusivity As An Efficient Incentive Mechanism”, Science and Technology Law Review, 11. doi: 10.7916/stlr.v11i0.3846.